BOVE, MARILISA
 Distribuzione geografica
Continente #
NA - Nord America 1.780
EU - Europa 1.294
AS - Asia 545
AF - Africa 99
SA - Sud America 6
OC - Oceania 2
Totale 3.726
Nazione #
US - Stati Uniti d'America 1.779
GB - Regno Unito 386
DE - Germania 218
CN - Cina 214
SE - Svezia 166
IT - Italia 165
SG - Singapore 119
IN - India 89
UA - Ucraina 80
VN - Vietnam 78
IE - Irlanda 67
FR - Francia 57
CI - Costa d'Avorio 45
RU - Federazione Russa 39
EE - Estonia 30
JO - Giordania 27
ZA - Sudafrica 25
TG - Togo 23
BG - Bulgaria 21
CH - Svizzera 18
GR - Grecia 10
RO - Romania 7
ES - Italia 6
SC - Seychelles 6
CL - Cile 5
NL - Olanda 5
TR - Turchia 5
AT - Austria 4
BE - Belgio 4
ID - Indonesia 4
PL - Polonia 4
AU - Australia 2
FI - Finlandia 2
HK - Hong Kong 2
IQ - Iraq 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CA - Canada 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
Totale 3.726
Città #
Southend 352
Fairfield 246
Ashburn 141
Chandler 137
Woodbridge 128
Seattle 104
Singapore 103
Houston 99
Wilmington 94
Princeton 93
Cambridge 91
Ann Arbor 67
Dublin 66
Dong Ket 60
Turin 46
Abidjan 45
Jacksonville 45
Westminster 39
Berlin 35
Nanjing 35
Padova 30
Bremen 28
Amman 27
Lomé 23
Santa Clara 23
Sofia 21
Bologna 19
Hebei 18
Dearborn 17
Jinan 17
Saint Petersburg 17
Bern 16
San Diego 14
Nanchang 13
Des Moines 11
Los Angeles 10
Shenyang 10
Milan 9
Taizhou 9
Beijing 8
Medford 8
Shanghai 8
Changsha 7
Olalla 7
Guangzhou 6
Paris 6
Redwood City 6
Bühl 5
Falls Church 5
Jiaxing 5
Mahé 5
Mountain View 5
Brussels 4
Jakarta 4
Ningbo 4
Rome 4
San Venanzo 4
Santiago 4
Tianjin 4
Zhengzhou 4
Barcelona 3
Boardman 3
Chicago 3
Dongguan 3
Groningen 3
Hangzhou 3
Karditsa 3
Kayseri 3
Kunming 3
London 3
Redmond 3
Taiyuan 3
Verona 3
Xi'an 3
Amsterdam 2
Boydton 2
Buffalo 2
Chengdu 2
Falkenstein 2
Florence 2
Frankfurt Am Main 2
Haikou 2
Hefei 2
Kuban 2
Kuehnsdorf 2
Lahore 2
Lanzhou 2
Melbourne 2
Moscow 2
Mülheim 2
New York 2
Norwalk 2
Prineville 2
Provo 2
Pune 2
Salerno 2
San Bonifacio 2
Shenzhen 2
Shijiazhuang 2
Wenzhou 2
Totale 2.565
Nome #
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 132
null 131
Sources of variabilità of plasma HDL-cholesterol levels. 117
An evidence-based review on urate-lowering treatments: Implications for optimal treatment of chronic hyperuricemia 113
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study 109
Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial 100
null 98
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 98
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 95
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 94
null 93
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 93
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 91
Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome. 88
Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale 86
Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation 83
null 82
Role of olive oil in the health: results form the Eurolive Study. 79
null 75
null 75
LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort 74
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial 74
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 73
null 73
Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial 71
null 71
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 71
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 70
Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. 70
null 68
Emerging drugs for the treatment of hypercholesterolemia 67
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 65
null 64
null 62
Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia. 60
Prevalent seasoning and cooking fats, arterial stiffness and lipid pattern in a rural population sample: data from the Brisighella Heart Study 60
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial 58
Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia. 56
Efficacy and safety of Armolipid Plus®: an updated PRISMA compliant systematic review and meta-analysis of randomized controlled clinical trials. 52
null 51
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. 48
Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. 47
Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic 45
Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209 43
Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular Disease 42
Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection 42
Evaluation of the short term efficacy and tolerability of a combined nutraceutical with lipid lowering properties: a randomized clinical trial. 41
Successful treatment of a patient with mitochondrial myopathy with alirocumab 39
Effect of a sequential training program on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome 38
Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. 33
Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. 33
Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approach 24
LDL-oxidation, serum uric acid and pulse-wave velocity relationship in chronic kidney disease: Data from the Brisighella heart study cohort 20
Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia 20
The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function 18
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product 13
Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial 13
Prevalence of Hypo- and Hyperalphalipoproteinemia according to different diagnostic criteria in the massa lombarda project cohort 8
Sources of variability of plasma HDL-cholesterol levels. 7
EFFECT OF QUANTITATIVE AND QUALITATIVE DIET PRESCRIPTION ON CHILDREN BEHAVIOUR AFTER A DIAGNOSIS OF FAMILIAL DYSLIPIDEMIA 7
MMP-2, MMP-9 and their inhibitors and other prothrombotic risk factors plasma level in FCH, MS, FCH plus MS and control subjects 5
Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate 3
CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING 3
Efficacy of soluble fiber supplementation in CVD risk management of patients affected by metabolic syndrome: A 6-months, open-label, RCT 3
NUTRACEUTICAL EFFECTS ON GLUCOSE AND LIPID METABOLISM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: A PILOT, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL 2
Totale 3.839
Categoria #
all - tutte 10.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020777 0 0 0 45 91 102 118 141 120 81 28 51
2020/2021470 122 29 18 22 4 27 13 27 52 37 24 95
2021/2022737 73 17 40 26 83 50 9 37 38 24 214 126
2022/2023867 66 99 25 140 57 53 34 43 192 37 84 37
2023/2024202 5 46 20 26 15 34 12 21 2 15 3 3
2024/2025287 25 135 89 38 0 0 0 0 0 0 0 0
Totale 3.839